391 related articles for article (PubMed ID: 18079965)
21. Receptor for advanced glycation endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cells.
Pollreisz A; Hudson BI; Chang JS; Qu W; Cheng B; Papapanou PN; Schmidt AM; Lalla E
Atherosclerosis; 2010 Oct; 212(2):451-6. PubMed ID: 20701913
[TBL] [Abstract][Full Text] [Related]
22. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
[TBL] [Abstract][Full Text] [Related]
23. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y
Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597
[TBL] [Abstract][Full Text] [Related]
24. RAGE: a novel target for drug intervention in diabetic vascular disease.
Hudson BI; Schmidt AM
Pharm Res; 2004 Jul; 21(7):1079-86. PubMed ID: 15290845
[TBL] [Abstract][Full Text] [Related]
25. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings.
Stern D; Yan SD; Yan SF; Schmidt AM
Adv Drug Deliv Rev; 2002 Dec; 54(12):1615-25. PubMed ID: 12453678
[TBL] [Abstract][Full Text] [Related]
26. S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.
Oesterle A; Bowman MA
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2496-507. PubMed ID: 26515415
[TBL] [Abstract][Full Text] [Related]
27. The receptor for advanced glycation end products mediates lung endothelial activation by RBCs.
Mangalmurti NS; Friedman JL; Wang LC; Stolz D; Muthukumaran G; Siegel DL; Schmidt AM; Lee JS; Albelda SM
Am J Physiol Lung Cell Mol Physiol; 2013 Feb; 304(4):L250-63. PubMed ID: 23275625
[TBL] [Abstract][Full Text] [Related]
28. The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice.
Lee D; Lee KH; Park H; Kim SH; Jin T; Cho S; Chung JH; Lim S; Park S
PLoS One; 2013; 8(8):e69669. PubMed ID: 23936343
[TBL] [Abstract][Full Text] [Related]
29. RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model.
Aleshin A; Ananthakrishnan R; Li Q; Rosario R; Lu Y; Qu W; Song F; Bakr S; Szabolcs M; D'Agati V; Liu R; Homma S; Schmidt AM; Yan SF; Ramasamy R
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1823-32. PubMed ID: 18245563
[TBL] [Abstract][Full Text] [Related]
30. AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis.
Nienhuis HL; Westra J; Smit AJ; Limburg PC; Kallenberg CG; Bijl M
Autoimmunity; 2009 May; 42(4):302-4. PubMed ID: 19811283
[TBL] [Abstract][Full Text] [Related]
31. Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis.
Ramasamy R; Yan SF; Herold K; Clynes R; Schmidt AM
Ann N Y Acad Sci; 2008 Apr; 1126():7-13. PubMed ID: 18448789
[TBL] [Abstract][Full Text] [Related]
32. miR-21-3p regulates AGE/RAGE signalling and improves diabetic atherosclerosis.
Shao M; Yu M; Zhao J; Mei J; Pan Y; Zhang J; Wu H; Yu M; Liu F; Chen G
Cell Biochem Funct; 2020 Oct; 38(7):965-975. PubMed ID: 32196704
[TBL] [Abstract][Full Text] [Related]
33. Soluble RAGE attenuates AngII-induced endothelial hyperpermeability by disrupting HMGB1-mediated crosstalk between AT1R and RAGE.
Jeong J; Lee J; Lim J; Cho S; An S; Lee M; Yoon N; Seo M; Lim S; Park S
Exp Mol Med; 2019 Sep; 51(9):1-15. PubMed ID: 31562296
[TBL] [Abstract][Full Text] [Related]
34. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.
Kislinger T; Tanji N; Wendt T; Qu W; Lu Y; Ferran LJ; Taguchi A; Olson K; Bucciarelli L; Goova M; Hofmann MA; Cataldegirmen G; D'Agati V; Pischetsrieder M; Stern DM; Schmidt AM
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):905-10. PubMed ID: 11397695
[TBL] [Abstract][Full Text] [Related]
35. [Role of the receptor for advanced glycation end products (RAGE) in inflammation].
Mosquera JA
Invest Clin; 2010 Jun; 51(2):257-68. PubMed ID: 20928981
[TBL] [Abstract][Full Text] [Related]
36. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications.
Bierhaus A; Nawroth PP
Diabetologia; 2009 Nov; 52(11):2251-63. PubMed ID: 19636529
[TBL] [Abstract][Full Text] [Related]
37. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
[TBL] [Abstract][Full Text] [Related]
38. Glucagon-like peptide-1 analogue liraglutide ameliorates atherogenesis via inhibiting advanced glycation end product-induced receptor for advanced glycosylation end product expression in apolipoprotein-E deficient mice.
Li P; Tang Z; Wang L; Feng B
Mol Med Rep; 2017 Sep; 16(3):3421-3426. PubMed ID: 28713911
[TBL] [Abstract][Full Text] [Related]
39. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
Lue LF; Yan SD; Stern DM; Walker DG
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
[TBL] [Abstract][Full Text] [Related]
40. The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis.
Menini S; Iacobini C; Ricci C; Blasetti Fantauzzi C; Salvi L; Pesce CM; Relucenti M; Familiari G; Taurino M; Pugliese G
Cardiovasc Res; 2013 Dec; 100(3):472-80. PubMed ID: 23975852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
